Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers

BACKGROUND: Direct primary care provision of first-trimester medical abortion could potentially address inequitable abortion access in Canada. However, when Health Canada approved the combination medication Mifegymiso® (mifepristone 200 mg/misoprostol 800 mcg) for medical abortion in July 2015, we h...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pilot Feasibility Stud
Auteurs principaux: Devane, Courtney, Renner, Regina M., Munro, Sarah, Guilbert, Édith, Dunn, Sheila, Wagner, Marie-Soleil, Norman, Wendy V.
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2019
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6839244/
https://ncbi.nlm.nih.gov/pubmed/31720004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-019-0520-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires